• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自癌症患者供体的角膜移植

Corneal transplantations from donors with cancer.

作者信息

López-Navidad Antonio, Soler Nuria, Caballero Francisco, Lerma Enrique, Gris Oscar

机构信息

Department of Organ and Tissue Procurement for Transplantation and Tissue Bank, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.

出版信息

Transplantation. 2007 May 27;83(10):1345-50. doi: 10.1097/01.tp.0000264199.31913.75.

DOI:10.1097/01.tp.0000264199.31913.75
PMID:17519785
Abstract

BACKGROUND

Acceptance criteria for corneal donation in some eye banks include cadavers with active cancer, both solid and hematological. Such acceptance is based on the fact that the cornea is an avascular tissue and metastatic dissemination is extremely unlikely.

METHODS

From a total of 588 corneal donors in the Sant Pau Tissue Bank (April 1999 to December 2003), 204 (34.7%) had an active malignancy or a history of malignancy. Of these, 177 had solid cancers and 27 had hematological cancers. Cancer was active in 94.7% and 64% had metastatic dissemination. A histopathological study of the 408 eyes from these 204 donors was performed to rule out metastasis. A total of 325 corneas (79.7%) were transplanted and recipients were followed for an average of 64.1 months (SD 11.1, range 30-86).

RESULTS

The incidence of ocular metastases in the 204 donors with malignancy was 1%, 0.6% for solid cancer, and 3.7% for malignant hematological disease. There was no tumor transmission in any of the 325 recipients.

CONCLUSIONS

The incidence of ocular metastases in corneal donors with active malignancy is very low. Donor-recipient tumor transmission through corneal transplantation is highly improbable when the eyes are free of cancer.

摘要

背景

一些眼库的角膜捐赠接受标准包括患有实体癌和血液系统癌症的尸体。这种接受基于角膜是无血管组织且极不可能发生转移扩散这一事实。

方法

在圣保禄组织库的588名角膜捐赠者中(1999年4月至2003年12月),204名(34.7%)有活动性恶性肿瘤或恶性肿瘤病史。其中,177名患有实体癌,27名患有血液系统癌症。94.7%的癌症处于活动期,64%有转移扩散。对这204名捐赠者的408只眼睛进行了组织病理学研究以排除转移。共移植了325只角膜(79.7%),对接受者平均随访了64.1个月(标准差11.1,范围30 - 86个月)。

结果

204名患有恶性肿瘤的捐赠者中眼转移的发生率为1%,实体癌为0.6%,恶性血液系统疾病为3.7%。325名接受者中均未发生肿瘤传播。

结论

患有活动性恶性肿瘤的角膜捐赠者中眼转移的发生率非常低。当眼睛无癌症时,通过角膜移植发生供体 - 受体肿瘤传播的可能性极小。

相似文献

1
Corneal transplantations from donors with cancer.来自癌症患者供体的角膜移植
Transplantation. 2007 May 27;83(10):1345-50. doi: 10.1097/01.tp.0000264199.31913.75.
2
In situ versus whole-globe harvesting of corneal tissue from remote donor sites: effects on initial tissue quality.来自偏远供体部位的角膜组织原位采集与全眼球采集:对初始组织质量的影响。
Cornea. 2007 Apr;26(3):270-3. doi: 10.1097/ICO.0b013e31802c9e05.
3
Transplanted corneal graft with metastatic cholangiocarcinoma to the donor eye.移植的角膜移植物伴胆管癌转移至供体眼。
Eye Contact Lens. 2008 Nov;34(6):340-2. doi: 10.1097/ICL.0b013e31818c25d9.
4
The Spanish National Transplant Organization (ONT) tumor registry.西班牙国家移植组织(ONT)肿瘤登记处。
Transplantation. 2008 Apr 27;85(8 Suppl):S61-3. doi: 10.1097/TP.0b013e31816c2f55.
5
Assessment of eye bank-prepared posterior lamellar corneal tissue for endothelial keratoplasty.用于内皮角膜移植术的眼库制备后板层角膜组织评估
Ophthalmology. 2008 Feb;115(2):279-86. doi: 10.1016/j.ophtha.2007.04.020. Epub 2007 Jun 28.
6
A population-based study of cancer incidence in solid organ transplants from donors at various risk of neoplasia.一项基于人群的研究,关于来自具有不同肿瘤发生风险供体的实体器官移植受者的癌症发病率。
Transplantation. 2007 Jan 15;83(1):13-6. doi: 10.1097/01.tp.0000247794.50318.4a.
7
Endothelial keratoplasty using donor tissue not suitable for full-thickness penetrating keratoplasty.使用不适用于全层穿透性角膜移植术的供体组织进行内皮角膜移植术。
Cornea. 2007 Jun;26(5):515-9. doi: 10.1097/ICO.0b013e3180335511.
8
Organ-cultured corneal grafts from septic donors: a retrospective study.来自感染供体的器官培养角膜移植:一项回顾性研究。
Eye (Lond). 2002 Sep;16(5):622-7. doi: 10.1038/sj.eye.6700145.
9
Donors with central nervous system malignancies: are they truly safe?患有中枢神经系统恶性肿瘤的捐赠者:他们真的安全吗?
Transplantation. 2003 Jul 27;76(2):340-3. doi: 10.1097/01.TP.0000076094.64973.D8.
10
Whole globe enucleation versus in situ excision for donor corneal retrieval--a prospective comparative study.供体角膜获取中全眼球摘除与原位切除的前瞻性对比研究
Cornea. 2008 Dec;27(10):1103-8. doi: 10.1097/ICO.0b013e31817f812e.

引用本文的文献

1
Views of admitted palliative care patients and their clinicians on corneal donation discussions: a qualitative content analysis of semi-structured interviews.收治的姑息治疗患者及其临床医生对角膜捐献讨论的看法:半结构化访谈的定性内容分析。
BMC Palliat Care. 2024 Apr 1;23(1):85. doi: 10.1186/s12904-024-01421-7.
2
Conjunctival melanoma following cornea transplant from a cancer donor: A case report.癌症供体角膜移植术后发生的结膜黑色素瘤:一例报告。
Am J Ophthalmol Case Rep. 2023 Jan 28;29:101809. doi: 10.1016/j.ajoc.2023.101809. eCollection 2023 Mar.
3
A single-cell transcriptomic atlas of the human ciliary body.
人类眼前房的单细胞转录组图谱。
Cell Mol Life Sci. 2022 Sep 26;79(10):528. doi: 10.1007/s00018-022-04559-w.
4
Barriers and Facilitators to Eye Donation in Hospice and Palliative Care Settings: A Scoping Review.临终关怀与姑息治疗环境中眼捐赠的障碍与促进因素:一项范围综述
Palliat Med Rep. 2021 Jun 16;2(1):175-187. doi: 10.1089/pmr.2021.0017. eCollection 2021.
5
Autologous Corneal Transplant from an Enucleated Fellow Eye for Choroidal Melanoma: A Case Report.来自摘除的对侧眼球的自体角膜移植治疗脉络膜黑色素瘤:一例报告
Case Rep Ophthalmol. 2020 May 14;11(2):181-188. doi: 10.1159/000507776. eCollection 2020 May-Aug.